← Back to headlines

Personalized mRNA Vaccine Shows Promise in Halting Cancer Recurrence
A breakthrough personalized mRNA vaccine has dramatically stopped cancer recurrence in clinical trials, offering new hope amid WHO warnings that global cancer cases could nearly double by 2050.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
